ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $12,845,000 | -52.1% | 317,786 | -31.7% | 0.01% | -52.6% |
| Q2 2015 | $26,794,000 | -7.3% | 465,561 | +2.6% | 0.02% | -5.0% |
| Q1 2015 | $28,903,000 | -11.3% | 453,941 | -14.0% | 0.02% | -4.8% |
| Q4 2014 | $32,601,000 | +42.4% | 528,032 | -10.4% | 0.02% | +31.2% |
| Q3 2014 | $22,894,000 | +313.5% | 589,590 | +266.8% | 0.02% | +300.0% |
| Q2 2014 | $5,537,000 | -36.2% | 160,735 | -20.0% | 0.00% | -33.3% |
| Q1 2014 | $8,685,000 | +257.7% | 200,986 | +229.7% | 0.01% | +200.0% |
| Q4 2013 | $2,428,000 | +116.8% | 60,966 | +104.4% | 0.00% | +100.0% |
| Q3 2013 | $1,120,000 | +78.1% | 29,823 | +27.4% | 0.00% | 0.0% |
| Q2 2013 | $629,000 | – | 23,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |